GeneDx (WGSWW) Competitors $0.16 0.00 (0.00%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsShort InterestTrends WGSWW vs. ACONW, BTSGU, BFRGW, CCLDP, CCLDO, CMAXW, EUDAW, BEATW, LFMDP, and LIFWZShould you be buying GeneDx stock or one of its competitors? The main competitors of GeneDx include Aclarion (ACONW), BrightSpring Health Services (BTSGU), Bullfrog AI (BFRGW), CareCloud (CCLDP), CareCloud (CCLDO), CareMax (CMAXW), EUDA Health (EUDAW), HeartBeam (BEATW), LifeMD (LFMDP), and MSP Recovery (LIFWZ). These companies are all part of the "health information services" industry. GeneDx vs. Aclarion BrightSpring Health Services Bullfrog AI CareCloud CareCloud CareMax EUDA Health HeartBeam LifeMD MSP Recovery GeneDx (NASDAQ:WGSWW) and Aclarion (NASDAQ:ACONW) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, media sentiment, risk, valuation, dividends, community ranking, analyst recommendations, earnings and institutional ownership. Does the media favor WGSWW or ACONW? In the previous week, GeneDx and GeneDx both had 1 articles in the media. GeneDx's average media sentiment score of 0.98 beat Aclarion's score of 0.00 indicating that GeneDx is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment GeneDx 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Aclarion 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Is WGSWW or ACONW more profitable? Company Net Margins Return on Equity Return on Assets GeneDxN/A N/A N/A Aclarion N/A N/A N/A Does the MarketBeat Community believe in WGSWW or ACONW? GeneDx and Aclarion both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformGeneDxN/AN/AAclarionN/AN/A Which has higher valuation & earnings, WGSWW or ACONW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGeneDx$267.23MN/AN/AN/AN/AAclarion$53.95KN/AN/AN/AN/A SummaryGeneDx beats Aclarion on 2 of the 2 factors compared between the two stocks. Ad Darwin2025 AI Stock Picks: 2 Hidden Gems Under $10/ShareThe AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.👉[Click here to get your FREE report delivered instantly!] Get GeneDx News Delivered to You Automatically Sign up to receive the latest news and ratings for WGSWW and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart WGSWW vs. The Competition Export to ExcelMetricGeneDxHealth Information Services IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$178.15M$5.03B$8.81BDividend YieldN/A6.51%5.16%4.06%P/E RatioN/A696.77135.4117.82Price / SalesN/A315.791,160.9774.56Price / CashN/A39.8433.5332.53Price / BookN/A4.614.674.68Net IncomeN/A-$7.17M$119.07M$226.08M7 Day Performance-20.74%-0.93%-1.83%-1.04%1 Month Performance-31.42%1.61%-3.60%1.04%1 Year PerformanceN/A0.37%31.66%26.28% GeneDx Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)WGSWWGeneDxN/A$0.16flatN/A+1,477.0%$0.00$267.23M0.001,000Gap UpACONWAclarionN/A$0.03flatN/AN/A$0.00$53,947.000.007BTSGUBrightSpring Health ServicesN/A$68.32+0.8%N/AN/A$0.00$10.59B0.0035,000BFRGWBullfrog AIN/A$0.20flatN/A-72.3%$0.00$65,000.000.002CCLDPCareCloudN/A$16.76-0.7%N/A-3.1%$0.00$111.01M0.003,600CCLDOCareCloudN/A$17.04-1.4%N/A+16.2%$0.00$111.01M0.003,600CMAXWCareMaxN/A$0.01flatN/A-95.2%$0.00$784.55M0.001,450Gap DownEUDAWEUDA HealthN/A$0.09flatN/A-51.2%$0.00$3.81M0.00150BEATWHeartBeamN/A$0.68+1.5%N/A+157.0%$0.00N/A0.005Gap UpLFMDPLifeMDN/A$22.00flatN/A+18.9%$0.00$193.06M0.00230LIFWZMSP RecoveryN/A$0.07-58.0%N/A-73.4%$0.00$10.73M0.0088Gap Down Related Companies and Tools Related Companies Aclarion Alternatives BrightSpring Health Services Alternatives Bullfrog AI Alternatives CareCloud Alternatives CareCloud Alternatives CareMax Alternatives EUDA Health Alternatives HeartBeam Alternatives LifeMD Alternatives MSP Recovery Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:WGSWW) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GeneDx Holdings Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share GeneDx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
